Expensive drugs that cure hepatitis C are worth the cost, even at early stages of liver fibrosis

It is cost effective to give patients expensive new hepatitis C drugs much earlier than some insurers now pay for them. Researchers were surprised by these findings, since the drugs can cost up to $100,000. But when they factored in the long-term medical cost of delaying treatment for hepatitis C, they found the savings, in combination with improvements in the quality of patients' lives, were enough to justify using them at early stages of liver fibrosis.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1lk605v